Phase 1b single and multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of HT-100 in DMD

被引：0
|
作者：
Escolar, D. M. [1 ,2 ]
Davis-Golden, J. [3 ]
Loewy, J. [4 ]
Bush, E. [5 ]
Dykstra, K. [4 ]
Blaustein, M. [5 ]
机构：
[1] Kennedy Krieger Inst, Baltimore, MD USA
[2] Halo Therapeut LLC, Baltimore, MD USA
[3] Halo Therapeut, Newton, MA USA
[4] Pharmetra LLC, Boston, MA USA
[5] Halo Therapeut LLC, Newton, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2013年 / 23卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2013.06.575
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：802 / 803
页数：2
相关论文
共 50 条
  • [1] HT-100: Interim safety, pharmacokinetics, and pharmacodynamic data in DMD boys
    Escolar, D.
    Blaustein, M.
    Bush, E.
    Wagner, K.
    Wong, B.
    Flanigan, K.
    Han, J.
    Britton, A.
    Loewy, J.
    Dykstra, K.
    Connolly, A.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S263 - S263
  • [2] A phase 1 single ascending dose study of the safety, tolerability and pharmacokinetics of CRV431
    Armas, Danielle
    Snyder, Michael
    Trepanier, Daniel
    Ure, Daren
    Greytok, Jill
    Foster, Robert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E464 - E465
  • [3] Safety, tolerability and treatment effectiveness of chronic hepatitis B patients with pradefovir: a phase 1b multiple ascending dose study
    Jingrui, L.
    Junqi, N.
    Yanhua, D.
    Ning, X.
    Xiaoxue, Z.
    Xiaojiao, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S105 - S105
  • [4] Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial
    Hernandez, Gerson D.
    Solinsky, Christine M.
    Mack, Wendy J.
    Kono, Naoko
    Rodgers, Kathleen E.
    Wu, Chun-Yi
    Mollo, Ana R.
    Lopez, Claudia M.
    Pawluczyk, Sonia
    Bauer, Gerhard
    Matthews, Dawn
    Shi, Yonggang
    Law, Meng
    Rogawski, Michael A.
    Schneider, Lon S.
    Brinton, Roberta D.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [5] Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
    Bruinenberg, Paul
    Nedelman, Jerry
    Yang, Tian J.
    Pappas, Fran
    Everitt, Dan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)
  • [6] A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects
    Yue, Patrick
    Qu, Emma
    Pan, Jie
    Weitz, Jeffrey
    Ji, Qunsheng
    BLOOD, 2024, 144 : 4009 - 4010
  • [7] Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
    Merica, VarshaIyer Elizabeth
    Ronseaux, Sebastien
    Gamache, Tressa
    Mulrow, Nancy J.
    Belcijan, Anja
    Callaghan, Michael U.
    BLOOD, 2021, 138
  • [8] A Multiple Ascending-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirogabalin in Healthy Elderly Subjects
    Brown, Karen
    Kumagae, Yoshihiro
    Ohwada, Shoichi
    Warren, Vance
    Zahir, Hamim
    Dishy, Victor
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects
    G Tong
    I Savant
    N Jariwala
    D Burt
    N Zheng
    A Buzescu
    R Bertz
    S Keswani
    R Marcus
    The Journal of Headache and Pain, 2013, 14
  • [10] Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects
    Tong, G.
    Savant, I.
    Jariwala, N.
    Burt, D.
    Zheng, N.
    Buzescu, A.
    Bertz, R.
    Keswani, S.
    Marcus, R.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
12345